Edelman Joseph

10% OwnerLyra Therapeutics, Inc. (LYRA) · full profile →Form 4 · filed Nov 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$344K
Net Open-Market Flow
-$344K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 10, 2025Sell(S)2K$4.54$8K19K
Nov 10, 2025Sell(S)17K$4.54$76K166K
Nov 7, 2025Sell(S)2K$4.75$9K21K
Nov 7, 2025Sell(S)18K$4.75$84K183K
Nov 6, 2025Sell(S)29K$5.18$150K200K
Nov 6, 2025Sell(S)3K$5.18$17K23K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-274540) within minutes of acceptance. Every field above traces to the original document. Verify it directly: